Oryn Therapeutics Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Oryn Therapeutics is a clinical-stage company developing a new class of drug candidates, Orynotides. These proprietary macrocycles are uniquely engineered, stable peptides with very low immunogenicity and favorable safety profile. They modulate chronic inflammatory diseases and hold the ability to restore the immune homeostasis.